Global Interventional Cardiology Market Growth 2019-2024
Table of Contents
2019-2024 Global Interventional Cardiology Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Interventional Cardiology Consumption 2014-2024
- 2.1.2 Interventional Cardiology Consumption CAGR by Region
- 2.2 Interventional Cardiology Segment by Type
- 2.2.1 Cardiology catheters
- 2.2.2 Guidewires
- 2.2.3 Balloon catheters
- 2.2.4 Coronary stents
- 2.2.5 Fractional flow reserve
- 2.2.6 Intravascular ultrasound
- 2.3 Interventional Cardiology Consumption by Type
- 2.3.1 Global Interventional Cardiology Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Interventional Cardiology Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Interventional Cardiology Sale Price by Type (2014-2019)
- 2.4 Interventional Cardiology Segment by Application
- 2.4.1 Application I
- 2.4.2 Application II
- 2.5 Interventional Cardiology Consumption by Application
- 2.5.1 Global Interventional Cardiology Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Interventional Cardiology Value and Market Share by Application (2014-2019)
- 2.5.3 Global Interventional Cardiology Sale Price by Application (2014-2019)
3 Global Interventional Cardiology by Players
- 3.1 Global Interventional Cardiology Sales Market Share by Players
- 3.1.1 Global Interventional Cardiology Sales by Players (2017-2019)
- 3.1.2 Global Interventional Cardiology Sales Market Share by Players (2017-2019)
- 3.2 Global Interventional Cardiology Revenue Market Share by Players
- 3.2.1 Global Interventional Cardiology Revenue by Players (2017-2019)
- 3.2.2 Global Interventional Cardiology Revenue Market Share by Players (2017-2019)
- 3.3 Global Interventional Cardiology Sale Price by Players
- 3.4 Global Interventional Cardiology Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Interventional Cardiology Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Interventional Cardiology Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Interventional Cardiology by Regions
- 4.1 Interventional Cardiology by Regions
- 4.1.1 Global Interventional Cardiology Consumption by Regions
- 4.1.2 Global Interventional Cardiology Value by Regions
- 4.2 Americas Interventional Cardiology Consumption Growth
- 4.3 APAC Interventional Cardiology Consumption Growth
- 4.4 Europe Interventional Cardiology Consumption Growth
- 4.5 Middle East & Africa Interventional Cardiology Consumption Growth
5 Americas
- 5.1 Americas Interventional Cardiology Consumption by Countries
- 5.1.1 Americas Interventional Cardiology Consumption by Countries (2014-2019)
- 5.1.2 Americas Interventional Cardiology Value by Countries (2014-2019)
- 5.2 Americas Interventional Cardiology Consumption by Type
- 5.3 Americas Interventional Cardiology Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Interventional Cardiology Consumption by Countries
- 6.1.1 APAC Interventional Cardiology Consumption by Countries (2014-2019)
- 6.1.2 APAC Interventional Cardiology Value by Countries (2014-2019)
- 6.2 APAC Interventional Cardiology Consumption by Type
- 6.3 APAC Interventional Cardiology Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Interventional Cardiology by Countries
- 7.1.1 Europe Interventional Cardiology Consumption by Countries (2014-2019)
- 7.1.2 Europe Interventional Cardiology Value by Countries (2014-2019)
- 7.2 Europe Interventional Cardiology Consumption by Type
- 7.3 Europe Interventional Cardiology Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Interventional Cardiology by Countries
- 8.1.1 Middle East & Africa Interventional Cardiology Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Interventional Cardiology Value by Countries (2014-2019)
- 8.2 Middle East & Africa Interventional Cardiology Consumption by Type
- 8.3 Middle East & Africa Interventional Cardiology Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Interventional Cardiology Distributors
- 10.3 Interventional Cardiology Customer
11 Global Interventional Cardiology Market Forecast
- 11.1 Global Interventional Cardiology Consumption Forecast (2019-2024)
- 11.2 Global Interventional Cardiology Forecast by Regions
- 11.2.1 Global Interventional Cardiology Forecast by Regions (2019-2024)
- 11.2.2 Global Interventional Cardiology Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Interventional Cardiology Forecast by Type
- 11.8 Global Interventional Cardiology Forecast by Application
12 Key Players Analysis
- 12.1 Medtronic, Inc.
- 12.1.1 Company Details
- 12.1.2 Interventional Cardiology Product Offered
- 12.1.3 Medtronic, Inc. Interventional Cardiology Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Medtronic, Inc. News
- 12.2 Boston Scientific Corporation
- 12.2.1 Company Details
- 12.2.2 Interventional Cardiology Product Offered
- 12.2.3 Boston Scientific Corporation Interventional Cardiology Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Boston Scientific Corporation News
- 12.3 Abbott Vascular
- 12.3.1 Company Details
- 12.3.2 Interventional Cardiology Product Offered
- 12.3.3 Abbott Vascular Interventional Cardiology Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Abbott Vascular News
- 12.4 MINVASYS S.A.S.
- 12.4.1 Company Details
- 12.4.2 Interventional Cardiology Product Offered
- 12.4.3 MINVASYS S.A.S. Interventional Cardiology Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 MINVASYS S.A.S. News
- 12.5 BIOTRONIK SE & Co. KG
- 12.5.1 Company Details
- 12.5.2 Interventional Cardiology Product Offered
- 12.5.3 BIOTRONIK SE & Co. KG Interventional Cardiology Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 BIOTRONIK SE & Co. KG News
- 12.6 Bard Peripheral Vascular，Inc
- 12.6.1 Company Details
- 12.6.2 Interventional Cardiology Product Offered
- 12.6.3 Bard Peripheral Vascular，Inc Interventional Cardiology Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Bard Peripheral Vascular，Inc News
- 12.7 TERUMO CORPORATION
- 12.7.1 Company Details
- 12.7.2 Interventional Cardiology Product Offered
- 12.7.3 TERUMO CORPORATION Interventional Cardiology Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 TERUMO CORPORATION News
- 12.8 KANEKA
- 12.8.1 Company Details
- 12.8.2 Interventional Cardiology Product Offered
- 12.8.3 KANEKA Interventional Cardiology Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 KANEKA News
- 12.9 OrbusNeich Medical, BV
- 12.9.1 Company Details
- 12.9.2 Interventional Cardiology Product Offered
- 12.9.3 OrbusNeich Medical, BV Interventional Cardiology Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 OrbusNeich Medical, BV News
- 12.10 Cordis Cashel
- 12.10.1 Company Details
- 12.10.2 Interventional Cardiology Product Offered
- 12.10.3 Cordis Cashel Interventional Cardiology Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Cordis Cashel News
- 12.11 Kimal Plc
- 12.12 Volcano Corporation
- 12.13 Siemens Medical Solutions USA, Inc
- 12.14 Lepu
- 12.15 MicroPort
13 Research Findings and Conclusion
Interventional Cardiology is a kind of devices which is used in the treatment of cardiology area. Interventional Cardiology include cardiology catheters, guidewires, balloon catheters, coronary stents, fractional flow reserve (FFR), intravascular ultrasound.
In the next five years, the global consumption of Interventional Cardiology will maintain more than 3% annual growth rate, Industry is mainly concentrated in Europe, USA, Japan and China.
At present, Chinese market is mainly occupied by imported brands. The domestic enterprise technology still needs to develop.
As Chinese number of heart disease and cardiovascular disease people is increasing, Chinese Interventional Cardiology market is predicted to be growing fast.
Average industry gross margin is between 70% and 80%, that is to say, Interventional Cardiology Project is a good investment choice. However, disadvantage factors and threat such as serious competition in Interventional Cardiology Industry should be considered.
According to this study, over the next five years the Interventional Cardiology market will register a 3.1% CAGR in terms of revenue, the global market size will reach US$ 3 million by 2024, from US$ 3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Interventional Cardiology business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Cardiology market by product type, application, key manufacturers and key regions and countries.
This study considers the Interventional Cardiology value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Cardiology catheters
Guidewires
Balloon catheters
Coronary stents
Fractional flow reserve
Intravascular ultrasound
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Application I
Application II
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic, Inc.
Boston Scientific Corporation
Abbott Vascular
MINVASYS S.A.S.
BIOTRONIK SE & Co. KG
Bard Peripheral Vascular，Inc
TERUMO CORPORATION
KANEKA
OrbusNeich Medical, BV
Cordis Cashel
Kimal Plc
Volcano Corporation
Siemens Medical Solutions USA, Inc
Lepu
MicroPort
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Interventional Cardiology consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Interventional Cardiology market by identifying its various subsegments.
Focuses on the key global Interventional Cardiology manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Interventional Cardiology with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Interventional Cardiology submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.